Anders Widmark

13.6k total citations · 4 hit papers
173 papers, 7.2k citations indexed

About

Anders Widmark is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anders Widmark has authored 173 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 37 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anders Widmark's work include Prostate Cancer Treatment and Research (101 papers), Prostate Cancer Diagnosis and Treatment (79 papers) and Advanced Radiotherapy Techniques (24 papers). Anders Widmark is often cited by papers focused on Prostate Cancer Treatment and Research (101 papers), Prostate Cancer Diagnosis and Treatment (79 papers) and Advanced Radiotherapy Techniques (24 papers). Anders Widmark collaborates with scholars based in Sweden, United Kingdom and Norway. Anders Widmark's co-authors include Anders Bergh, Per Fransson, Pernilla Wikström, Jan‐Erik Damber, Lucia Mincheva‐Nilsson, Vladimir Baranov, Sead Crnalic, Johan Skog, Pär Stattin and Annika Nordstrand and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anders Widmark

162 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

2009 620 citations Johan Skog, Annika Nordstrand et al. profile →
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

2008 594 citations Anders Widmark, Arne Solberg et al. profile →
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

2019 559 citations Anders Widmark, Adalsteinn Gunnlaugsson et al. profile →
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

2011 381 citations Erik Bovinder Ylitalo, Sead Crnalic et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Widmark Sweden	43	4.2k	1.8k	1.6k	1.5k	1.1k	173	7.2k
Lioe‐Fee de Geus‐Oei Netherlands	39	2.6k 0.6×	1.4k 0.8×	2.0k 1.2×	1.0k 0.7×	1.3k 1.3×	238	7.7k
Manfred P. Wirth Germany	48	4.9k 1.2×	2.2k 1.2×	1.6k 1.0×	1.2k 0.8×	2.3k 2.2×	442	9.3k
Vivian Weinberg United States	45	3.4k 0.8×	895 0.5×	2.2k 1.3×	761 0.5×	2.1k 2.0×	173	7.8k
Cary N. Robertson United States	42	3.1k 0.7×	1.8k 1.0×	2.3k 1.4×	802 0.6×	1.3k 1.3×	132	8.1k
Leonard G. Gomella United States	63	6.7k 1.6×	3.4k 1.9×	2.5k 1.6×	2.5k 1.7×	2.6k 2.5×	385	12.7k
David F. Jarrard United States	49	5.0k 1.2×	4.0k 2.3×	2.1k 1.3×	2.0k 1.4×	920 0.9×	207	10.0k
Nobuo Shinohara Japan	40	2.6k 0.6×	1.7k 1.0×	1.2k 0.7×	877 0.6×	1.6k 1.5×	318	6.2k
Charles Lu United States	32	2.7k 0.6×	1.5k 0.8×	3.1k 1.9×	864 0.6×	2.5k 2.4×	100	8.3k
Stephen Y. Lai United States	51	1.9k 0.4×	1.9k 1.1×	2.7k 1.7×	1.1k 0.7×	2.0k 1.9×	271	8.3k
Jourik A. Gietema Netherlands	56	2.1k 0.5×	3.0k 1.7×	3.5k 2.1×	1.4k 1.0×	2.4k 2.3×	252	10.1k

Countries citing papers authored by Anders Widmark

Since Specialization

Citations

This map shows the geographic impact of Anders Widmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Widmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Widmark more than expected).

Fields of papers citing papers by Anders Widmark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Widmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Widmark. The network helps show where Anders Widmark may publish in the future.

Co-authorship network of co-authors of Anders Widmark

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Widmark. A scholar is included among the top collaborators of Anders Widmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Widmark. Anders Widmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nilsson, P., Adalsteinn Gunnlaugsson, L. Beckman, et al.. (2026). Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial. The Lancet Oncology. 27(3). 293–301.

Söderkvist, Karin, Adalsteinn Gunnlaugsson, Joakim Jönsson, et al.. (2024). Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging. Physics and Imaging in Radiation Oncology. 31. 100633–100633. 3 indexed citations

Josefsson, Andreas, Erik Holmberg, Klaus Brasso, et al.. (2023). Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14). Acta Oncologica. 62(4). 372–380. 3 indexed citations

Semenas, Julius, Sofia Halin Bergström, Marie Lundholm, et al.. (2023). Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328. Cancers. 15(9). 2437–2437. 3 indexed citations

Jönsson, Joakim, Jan Axelsson, Karin Söderkvist, et al.. (2023). The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography. SHILAP Revista de lepidopterología. 3(1). 164–164. 2 indexed citations

Wikström, Pernilla, Sofia Halin Bergström, Andreas Josefsson, et al.. (2022). Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy. Cancers. 14(21). 5195–5195. 7 indexed citations

Beckmann, Kerri, Hans Garmo, Per Nilsson, et al.. (2020). Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016. Acta Oncologica. 59(5). 549–557. 10 indexed citations

Nilsson, R. Jonas A., Leonora Balaj, Esther Hulleman, et al.. (2019). Supplemental data for Blood platelets contain tumor-derived RNA biomarkers. Pure Amsterdam UMC.

Johansson, Lennart, Jan Axelsson, Joakim Jönsson, et al.. (2019). Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients. EJNMMI Physics. 6(1). 2–2. 27 indexed citations

10.

Iglesias‐Gato, Diego, Elin Thysell, Stefka Tyanova, et al.. (2018). The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications. Clinical Cancer Research. 24(21). 5433–5444. 66 indexed citations

11.

Nordstrand, Annika, Sofia Halin Bergström, Elin Thysell, et al.. (2017). Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone. Clinical & Experimental Metastasis. 34(3-4). 261–271. 13 indexed citations

12.

Viset, Trond, et al.. (2016). Radiation Therapy Did Not Induce Long-Term Changes in Rectal Mucosa: Results From the Randomized Scandinavian Prostate Cancer Group 7 Trial. International Journal of Radiation Oncology*Biology*Physics. 95(4). 1268–1272. 2 indexed citations

13.

Widmark, Anders, Per Fransson, Peter Iversen, et al.. (2014). Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer. Scandinavian Journal of Urology. 49(1). 58–69. 5 indexed citations

14.

O’Sullivan, Joe M., Dag Clement Johannessen, Anders Widmark, et al.. (2013). Hematologic safety of radium-223 dichloride (Ra-223) in the phase 3 ALSYMPCA trial in castration-resistant prostate cancer (CRPC) patients with bone metastases : baseline prognostic factor subgroup analysis. European Journal of Cancer. 49. 3 indexed citations

15.

Widmark, Anders, Svein Inge Helle, Nicola James, et al.. (2013). Hematologic Safety Profile of Radium-223 Dichloride (Ra-223) From the Phase 3 ALSYMPCA Trial in Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastases. European Journal of Nuclear Medicine and Molecular Imaging. 40.

16.

Lund, Jo‐Åsmund, Arne Wibe, Anders Widmark, Arne Solberg, & Stein Kaasa. (2013). Late Effects to the Rectum and Anus in Prostate Cancer Patients Randomized to Hormonal Therapy Versus Hormonal Therapy Plus Radiotherapy. Journal of Gastroenterology and Hepatology Research. 2(10). 827–832. 2 indexed citations

17.

Horti, J, Anders Widmark, Arnulf Stenzl, et al.. (2009). A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer. Cancer Biotherapy and Radiopharmaceuticals. 24(2). 175–180. 39 indexed citations

18.

Widmark, Anders, Roger Henriksson, Jan‐Erik Damber, & Anders Bergh. (1994). Estramustine potentiates the effects of irradiation on the dunning (R3327) rat prostatic adenocarcinoma. The Prostate. 24(2). 79–83. 15 indexed citations

19.

Colin, Olivier, Anders Bergh, J‐E. Damber, & Anders Widmark. (1993). Control of testicular vasomotion by testosterone and tubular factors in rats. Reproduction. 97(1). 115–121. 45 indexed citations

20.

Widmark, Anders, Jan‐Erik Damber, & Anders Bergh. (1989). High and low doses of luteinizing hormone induce different changes in testicular microcirculation. European Journal of Endocrinology. 121(5). 621–627. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact